An Open-Label, Two Period Study to Determine the Excretion Balance and Pharmacokinetics of [14C]-GSK221149A, Administered as Single Doses of an Oral Solution and an Intravenous Infusion to Healthy Female Volunteers.
Phase of Trial: Phase I
Latest Information Update: 15 Mar 2012
At a glance
- Drugs Retosiban; Retosiban
- Indications Preterm labour
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 20 May 2009 Actual initiation date changed from Nov 2006 to Oct 2006 as reported by ClinicalTrials.gov.
- 16 Jun 2007 New trial record.